Concepedia
Statistics
Publications
1
Citations
56
H-Index
Active since
2021
Affiliations
Hamad Medical Corporation(Current)
Ahmed I. Soliman is an author at Hamad Medical Corporation.
Publications per year
2021–2021
Postmarketing safety of anaplastic lymphoma kinase (ALK) inhibitors: an analysis of the FDA Adverse Event Reporting System (FAERS)
Nabil E. Omar, Ahmed I. Soliman, Mohammad Reza Eshra et al. · ESMO Open · 2021 · 56 citations · Full text
1–1 of 1